# Idiopathic Intracranial Hypertension in a Non-obese Male Patient: A Case Report

**Authors:** Anas E Ahmed, Abdulmajeed F Alharbi, Muhannad M Alharbi, Ayah F Albalawai, Anas Y Shaheen

PMC · DOI: 10.7759/cureus.102170 · Cureus · 2026-01-23

## TL;DR

A non-obese man was diagnosed with idiopathic intracranial hypertension, a condition typically seen in obese women, and showed improvement with treatment.

## Contribution

This case report expands the understanding of idiopathic intracranial hypertension by presenting an atypical male, non-obese patient.

## Key findings

- The patient exhibited classic symptoms of IIH with elevated intracranial pressure confirmed by lumbar puncture.
- Neuroimaging showed features of raised intracranial pressure without mass lesions or venous sinus thrombosis.
- Conservative treatment with acetazolamide improved symptoms and prevented visual complications.

## Abstract

Idiopathic intracranial hypertension (IIH) is a disorder characterized by elevated intracranial pressure without an identifiable structural or secondary cause and is classically seen in obese women of childbearing age. We report a case of a 34-year-old non-obese male patient who presented with a six-month history of progressively worsening daily headaches, transient visual obscurations, and intermittent pulsatile tinnitus. Neurological examination revealed bilateral papilledema with preserved visual acuity, while laboratory investigations were unremarkable. Neuroimaging with computed tomography (CT) and magnetic resonance imaging (MRI) demonstrated features suggestive of raised intracranial pressure, including partial empty sella, posterior globe flattening, perioptic subarachnoid space distension, and optic nerve tortuosity, without evidence of mass lesion or venous sinus thrombosis. Lumbar puncture confirmed an elevated opening pressure of 32 cm H₂O with normal cerebrospinal fluid composition. A diagnosis of IIH was established after exclusion of secondary causes. The patient was managed conservatively with acetazolamide and symptomatic therapy, resulting in significant improvement in headache frequency and resolution of visual disturbances over three months, with stabilization of visual fields. This case highlights that IIH can occur in atypical populations, including non-obese men, and underscores the importance of early recognition, comprehensive evaluation, and timely intervention to prevent visual morbidity.

## Linked entities

- **Chemicals:** acetazolamide (PubChem CID 1986)
- **Diseases:** idiopathic intracranial hypertension (MONDO:0009468), papilledema (MONDO:0006879)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** coagulation (MESH:D001778), infection (MESH:D007239), pulsatile tinnitus (MESH:D014012), venous sinus thrombosis (MESH:D012851), endocrine disorders (MESH:D004700), vascular abnormalities (MESH:D014652), weight loss (MESH:D015431), IIH (MESH:D011559), chronic kidney disease (MESH:D051436), inflammatory (MESH:D007249), headache (MESH:D006261), anemia (MESH:D000740), papilledema (MESH:D010211), thrombosis (MESH:D013927), diplopia (MESH:D004172), visual disturbances (MESH:D014786), systemic illness (MESH:D012140), Pain (MESH:D010146), head trauma (MESH:D006259), venous outflow abnormalities (MESH:D006502), thyroid (MESH:D013966), seizures (MESH:D012640), hydrocephalus (MESH:D006849), stenosis (MESH:D003251), neurological deficits (MESH:D009461), sixth nerve palsy (MESH:D020434), fever (MESH:D005334), sleep apnea (MESH:D012891), intracranial mass lesion (MESH:C536030), vomiting (MESH:D014839), intracranial (MESH:D001932), empty (MESH:D004652), weight gain (MESH:D015430), intracranial hemorrhage (MESH:D020300), intracranial hypertension (MESH:D019586), obese (MESH:D009765), hemorrhage (MESH:D006470), adiposity (MESH:D018205), elevated (MESH:D006937), nausea (MESH:D009325), hyperemia (MESH:D006940)
- **Chemicals:** Acetazolamide (MESH:D000086), sodium (MESH:D012964), alcohol (MESH:D000438), glucose (MESH:D005947), H2O (MESH:D014867), tetracyclines (MESH:D013754), vitamin A (MESH:D014801)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926704/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926704/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926704/full.md

---
Source: https://tomesphere.com/paper/PMC12926704